BioPharmics LLC was founded in 1998 to develop algorithms and software for computational drug design. We have leading solutions in the areas of 2D to 3D ligand conversion and conformer generation (FGen3D and ForceGen), molecular docking (Surflex-Dock), molecular similarity (eSim), binding affinity prediction (QuanSA), and real-space modeling of ligand ensembles in X-ray density maps. All methods within the Surflex platform couple physical realism in modeling protein-ligand interactions with algorithms for rapid optimization of conformation and alignment of small molecules.
Company Details
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.biopharmics.com
Biopharmics Llc Questions
Biopharmics Llc's website is http://www.biopharmics.com
Biopharmics Llc's LinkedIn profile is https://www.linkedin.com/company/biopharmics-llc
Biopharmics Llc's industry is
Biotechnology Research
Biopharmics Llc's top competitors are
Optibrium,
Viva Biotech,
Abzena,
Qsimulate,
Snakker™,
Helia (Acquired By Scale Ai),
Oncomatryx Biopharma,
Openstore,
Merck & Co.,
Lunchclub.
Biopharmics Llc's categories are Biotechnology Research
Biopharmics Llc's founding year is 1998
